Comprehensive approaches for understanding the functional impact of genetic variation and genetic complexity

了解遗传变异和遗传复杂性的功能影响的综合方法

• 批准号: 10021020
• 负责人: AIMEE M DUDLEY
• 金额: $ 53.43万
• 依托单位: PACIFIC NORTHWEST RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-19 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10021020
• 关键词: Adult; Alleles; Amino Acid Sequence; Amino Acid Substitution; Amino Acids; Ammonia; Anabolism; Animal Model; Arginine; Benign; Biochemical Pathway; Biological; Biological Assay; Biomedical Research; Bipolar Disorder; Cerebral Edema; Cessation of life; Chemical Exposure; Childhood; Clinical; Code; Coma; Combinatorics; Complex; Crystallization; Databases; Development; Diagnosis; Diploidy; Disease; Enzymes; Experimental Designs; Gene Combinations; Genes; Genetic; Genetic Epistasis; Genetic Polymorphism; Genetic Variation; Genome; Genotype; Growth; Healthcare; Heterogeneity; Heterozygote; Human; Human Genetics; Human Genome; Individual; Infant; Knowledge; Life; Literature; Major Depressive Disorder; Measurement; Measures; Medical; Medical Genetics; Metabolic Diseases; Metabolic Pathway; Methods; Modeling; Molecular; Morbidity - disease rate; Nature; Neonatal; Operative Surgical Procedures; Pathogenicity; Pathway interactions; Persons; Phenotype; Population; Pregnancy; Proteins; Psychotic Disorders; Publishing; Savings; Seizures; Single Nucleotide Polymorphism; Structure; Symptoms; Testing; Time; Urea cycle disorders; Variant; Yeasts; combinatorial; cost; data integration; enzyme deficiency; exome sequencing; gene synthesis; genome sequencing; human disease; improved; in vivo; insight; loss of function; mortality; novel strategies; outcome forecast; personalized medicine; protein complex; protein function; variant of unknown significance

Project Summary/ Abstract: Our limited ability to relate genotype to phenotype is a major obstacle for biomedical research and personalized medicine. Currently only ~2% of germline missense variants have clinical interpretations, and the remainder, variants of uncertain significance (VUS), offer no information to inform diagnosis or guide treatment. As the clinical use of whole exome and genome sequencing increases, the number of VUS will skyrocket. Large-scale functional assays in model organisms are the only methods for variant interpretation currently poised to match the pace of variant discovery, and here we propose to extend their use to interpret genetic complexity. Our approach leverages the advent of low-cost, large-scale gene synthesis and the development of high throughput in vivo assays of protein function in model organisms, such as yeast. We propose a generalizable approach for determining the functional consequences of polymorphisms in human disease genes, including individual alleles, combinations of alleles in the same gene, and combinations of alleles in multiple genes in a pathway, on a massively parallel scale. The quantitative nature of our assay and the structure of our experimental design will allow us to compare the impact of allele combinations with their individual effects, and thus detect genetic epistasis (nonlinear genetic interactions) arising from naturally occurring human genetic variation outside of the limits of outbred human populations. Through this novel approach, we will not only explore the extent to which nonlinear interactions between human genes are pervasive or rare, but by placing them in the context of protein and metabolic pathway structure, we will gain insight into their molecular underpinnings. Our study will also provide an unprecedented amount of information about the contribution of individual amino acids to the function of the three disease-relevant enzymes in our study, and we will analyze our results in the context of their published crystal structures. Finally, we will develop new methods and assays that will expand the throughput, combinatorics, and number of assays available for functional analysis of human variation. We will pilot our approach using three human genes (OTC, ASS1, and ASL) associated with a class of metabolic disorders known as urea cycle disorders (UCD). Neonatal UCD is associated with severe enzyme deficiency. These infants rapidly develop high levels of ammonia, cerebral edema, and symptoms that can include seizures, coma, and death. Less severe forms may remain undiagnosed into childhood or adulthood. Late onset UCDs generally involve an environmental trigger (e.g. surgery, pregnancy, or chemical exposure) in individuals with reduced enzyme function. Diagnosis of the adult onset form is hampered by the fact that it often presents with symptoms such as episodic psychosis, bipolar disorder and major depression, and without treatment, prognosis is poor. Thus, knowledge of the functional implications of genetic variation in these genes has the potential to reduce the morbidity and mortality associated with delayed treatment or underdiagnosis.

项目摘要/摘要： 我们有限的将基因型与表型联系起来的能力是生物医学研究的主要障碍和个性化的 药品。目前，只有约2％的种系错线变体具有临床解释，其余的，其余的 具有不确定意义的变体（VUS），不提供任何信息来告知诊断或指导治疗。作为 整个外显子组和基因组测序的临床使用增加，VU的数量将飙升。大规模 模型生物中的功能分析是当前有准备匹配的变体解释的唯一方法 变体发现的速度，我们在这里提议扩展其用于解释遗传复杂性的用途。我们的 方法利用低成本，大规模基因合成和高吞吐量的发展 在模型生物（例如酵母）中的蛋白质功能的体内测定。我们提出了一种可推广的方法 确定人类疾病基因中多态性的功能后果，包括单个等位基因， 同一基因中等位基因的组合，以及在途径中的多个基因中等位基因的组合，在 大规模平行尺度。我们的测定的定量性质和实验设计的结构将 允许我们比较等位基因组合的影响与其个体效应，从而检测遗传 上毒（非线性遗传相互作用）是由自然发生的人类遗传变异引起的 近代人口的限制。通过这种新颖的方法，我们不仅将探讨 人基因之间的非线性相互作用是普遍或罕见的，但通过将其放置在蛋白质的背景下 和代谢途径结构，我们将深入了解它们的分子基础。我们的研究也将 提供有关单个氨基酸对功能的贡献的前所未有的信息 在我们的研究中，与疾病相关的三种酶中，我们将在其研究中分析我们的结果 已发表的晶体结构。最后，我们将开发新的方法和测定，以扩展吞吐量， 组合学和可用于人类变异功能分析的测定数量。 我们将使用与一类代谢相关的三个人类基因（OTC，ASS1和ASL）试行我们的方法 被称为尿素周期疾病（UCD）的疾病。新生儿UCD与严重的酶缺乏有关。 这些婴儿迅速发展高水平的氨，脑水肿和可能包括癫痫发作的症状 昏迷和死亡。不太严重的形式可能仍未诊断为童年或成年。发病迟到 通常涉及具有环境触发因素（例如手术，怀孕或化学暴露） 酶功能降低。成人发作形式的诊断受到了以下事实的阻碍 诸如情节性精神病，躁郁症和严重抑郁症等症状，没有治疗，预后 是贫穷的。因此，对这些基因遗传变异的功能含义的知识具有潜力 降低与延迟治疗或诊断不足有关的发病率和死亡率。